Subsidiary22 May 2026, 12:36 pm
Aurobindo Pharma: New Stepdown Subsidiary Incorporated in France
AI Summary
Aurobindo Pharma Ltd announced the incorporation of a new wholly-owned stepdown subsidiary, Arrow Pharma Production SAS, in France through its stepdown subsidiary Agile Pharma BV. Arrow Pharma Production SAS was created on May 21, 2026, with an authorized capital of 100,000 EUR. The new entity will focus on expanding the manufacturing of generic formulations in France. No governmental or regulatory approvals were required for the incorporation.
Key Highlights
- Aurobindo Pharma establishes Arrow Pharma Production SAS in France.
- Arrow Pharma Production SAS is a wholly-owned stepdown subsidiary.
- The new subsidiary will focus on generic formulations manufacturing.
- Authorized capital for Arrow Pharma Production SAS is 100,000 EUR.
- Agile Pharma BV is the holding company of Arrow Pharma Production SAS.
Price Impact
More from AUROPHARMA